Yingjie Zhang
18PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Mar 06, 2026
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency.Qipeng Chai, Maoshuo Yang, Chunxi Liu
|Apr 03, 2025
HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation.Maoshuo Yang, Wei Zhao, Jinwei Zhang
|Feb 11, 2025
Synthesis, biological and pharmacokinetic characterization of a novel leucine ureido derivative as a multi-target anticancer agent.Fangyuan Shi, Qifu Xu, Yingjie Zhang
|Oct 05, 2023
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer.Chunlong Zhao, Yu Zhang, Jin'ge Zhang
|Jul 18, 2023
Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity.Fengling Liu, Chunxi Liu, Qipeng Chai
|Apr 28, 2022
Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis.Jiangying Cao, Chunlong Zhao, Hang Dong
Pageof 3
